| Item Type | Name |
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
|
Academic Article
|
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
|
|
Academic Article
|
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
|
|
Academic Article
|
Cystic and inherited kidney diseases.
|
|
Academic Article
|
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
|
|
Academic Article
|
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
|
|
Academic Article
|
Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
|
|
Academic Article
|
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
|
|
Academic Article
|
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Blood pressure in early autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Hypertension in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Novel methodology to evaluate renal cysts in polycystic kidney disease.
|
|
Academic Article
|
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.
|
|
Academic Article
|
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
|
|
Academic Article
|
Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
|
|
Academic Article
|
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.
|
|
Academic Article
|
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Renal CD14 expression correlates with the progression of cystic kidney disease.
|
|
Academic Article
|
Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
|
|
Academic Article
|
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
|
|
Academic Article
|
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
|
|
Academic Article
|
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
|
|
Academic Article
|
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
|
|
Academic Article
|
Volume progression in polycystic kidney disease.
|
|
Academic Article
|
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.
|
|
Academic Article
|
Analysis of baseline parameters in the HALT polycystic kidney disease trials.
|
|
Academic Article
|
Liver involvement in early autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
|
|
Academic Article
|
Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Renal volume in children with ADPKD: size matters.
|
|
Academic Article
|
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
|
|
Academic Article
|
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
|
|
Academic Article
|
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial.
|
|
Academic Article
|
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
|
|
Academic Article
|
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
|
|
Academic Article
|
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.
|
|
Academic Article
|
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.
|
|
Academic Article
|
Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study.
|
|
Academic Article
|
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
|
|
Academic Article
|
The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Autosomal dominant polycystic kidney disease: time for a change?
|
|
Academic Article
|
Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Imaging approaches to patients with polycystic kidney disease.
|
|
Academic Article
|
Polycystic kidney disease: The cadence of kidney growth in ADPKD.
|
|
Academic Article
|
The spectrum of autosomal dominant polycystic kidney disease in children and adolescents.
|
|
Academic Article
|
The HALT polycystic kidney disease trials: design and implementation.
|
|
Academic Article
|
Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Performance of the CKD-EPI Equation to Estimate GFR in a Longitudinal Study of Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
|
|
Academic Article
|
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.
|
|
Academic Article
|
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
|
|
Academic Article
|
Pharmacokinetics and Pharmacodynamics of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: Phase 2 Trials for Dose Selection in the Pivotal Phase 3 Trial.
|
|
Academic Article
|
Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression.
|
|
Academic Article
|
Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
|
|
Academic Article
|
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
New treatment paradigms for ADPKD: moving towards precision medicine.
|
|
Academic Article
|
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.
|
|
Academic Article
|
Hypoxia-Inducible Factor 1a (HIF-1a), Angiopoietin-2 (ANG-2) and Endocan: Novel Biomarkers of Disease Progression Involving Polycystic Kidney Disease.
|
|
Academic Article
|
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.
|
|
Academic Article
|
Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
|
|
Academic Article
|
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
|
|
Academic Article
|
Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.
|
|
Academic Article
|
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4.
|
|
Academic Article
|
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
|
|
Academic Article
|
Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial.
|
|
Academic Article
|
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
|
|
Academic Article
|
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
|
|
Academic Article
|
Autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument.
|
|
Academic Article
|
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
|
|
Academic Article
|
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
|
|
Academic Article
|
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
|
|
Academic Article
|
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
|
|
Academic Article
|
Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.
|
|
Academic Article
|
Polycystins, ADPKD, and Cardiovascular Disease.
|
|
Academic Article
|
Core Outcome Domains for Trials in Autosomal Dominant Polycystic Kidney Disease: An International Delphi Survey.
|
|
Academic Article
|
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD.
|
|
Academic Article
|
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
|
|
Academic Article
|
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.
|
|
Academic Article
|
Mineral bone disease in autosomal dominant polycystic kidney disease.
|
|
Academic Article
|
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
|
|
Academic Article
|
Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.
|
|
Academic Article
|
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
|
|
Academic Article
|
Tolvaptan in ADPKD Patients With Very Low Kidney Function.
|
|
Academic Article
|
Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies.
|
|
Academic Article
|
PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.
|
|
Academic Article
|
Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.
|
|
Academic Article
|
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Polycystic Kidney Disease in the Real World.
|
|
Academic Article
|
Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
|
|
Academic Article
|
Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
|
|
Academic Article
|
Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial.
|
|
Academic Article
|
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
|
|
Academic Article
|
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
|
|
Grant
|
Symposium for Molecular and Therapeutic Insights in PKD
|
|
Grant
|
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria
|
|
Grant
|
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
|
|
Academic Article
|
Intracranial Aneurysms in ADPKD: How Far Have We Come?
|
|
Academic Article
|
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
|
|
Academic Article
|
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY.
|
|
Academic Article
|
Pregnancy in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
|
|
Academic Article
|
ALTERATIONS IN HISTIDINE METABOLISM IS A FEATURE OF EARLY AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD).
|
|
Academic Article
|
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.
|
|
Academic Article
|
Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD.
|
|
Academic Article
|
Does dopamine connect the dots in ADPKD?
|
|
Academic Article
|
The importance of quantifying genetic heterogeneity in ADPKD.
|
|
Academic Article
|
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program.
|
|
Academic Article
|
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary.
|
|
Academic Article
|
Effect of Race on Transplantation in Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Overweight Status, Obesity, and Progression to ESKD in Patients with Autosomal Dominant Polycystic Kidney Disease.
|
|
Academic Article
|
Validating the SONG-PKD Pain Instrument, a Core Outcome Measure for Pain in ADPKD.
|